The RMAT Designation: What it means to the advanced therapy supply chain
The ever-increasing demand for healthcare advances has prompted legislators to consider means of facilitating the development of potentially life-saving new therapies. In this guest blog, Alison Wilson will review the definition of a regenerative medicine advanced therapy (RMAT) and how this designation can facilitate speed to market for these innovative therapies. Alison is an independent regulatory affairs consultant specializing in human cell and tissue-based advanced therapies.
Topic: Cell Therapy Solutions, Content: Blog